Particulars |
Company Name |
Aurobindo Pharma Ltd |
Year End |
2023/03 |
Full Year |
Equity (Rs Cr.) |
58.59 |
B.V (Rs) |
318.50 |
Sales (Rs Cr.) |
12,792.28 |
NP. (Rs Cr.) |
1,220.43 |
NP Var% |
-21.00 |
Div% |
750.00 |
CPS (Rs) |
28.30 |
EPS (Rs) |
20.80 |
Traded Value (Rs Lakhs) |
108.03 |
52 Week High |
1,177.00 |
52 Week Low |
582.00 |
Price BSE |
1,084.00 |
Price NSE |
1,084.00 |
Market Capital (Rs Cr.) |
63,492.31 |
P/C Ratio |
38.40 |
P/E Ratio |
52.00 |
Price Vs.BV |
3.40 |
|
Latest Quarter |
Year End |
202312 |
Sales (Rs Cr.) |
2,663.87 |
NP (Rs Cr.) |
623.78 |
NP Var % |
93.00 |
Trailing Twelve Months |
Year End |
202312 |
Sales |
11,197.53 |
OPM |
10.11 |
NP |
1,400.90 |
NP Var% |
30.76 |
EPS |
33.56 |
PE |
32.29 |
|
|